Study reveals genetic mutations associated with aggressive prostate cancer
Pharma Times
JULY 4, 2024
Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses
Thu.Jul 04, 2024
132 
Changing Faces: Digital and supplier hires from April 2024
pharmaphorum
JULY 4, 2024
Changing Faces explores the digital and supplier hires from April 2024, with a focus on companies like SPT Labtech, Sphere Fluidics, Newel Health, and Diaceutics. Stay updated on the latest developments in the industry.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Herantis Pharma granted €3.6m to assess treatment for Parkinson’s disease
Pharma Times
JULY 4, 2024
In the UK, the progressive neurodegenerative condition affects around 153,000 people
Pieris loses Servier as partner for cancer immunotherapies
pharmaphorum
JULY 4, 2024
Pieris' immuno-oncology alliance with Servier is being dissolved after a trial of the lead drug in the alliance revealed a safety concern.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Addressing Oral Health Disparities: Insights from Industry Leaders on Tackling a Global Healthcare Crisis
XTalks
JULY 4, 2024
Oral health disparities continue to impact underserved communities around the world. These disparities stem from multiple barriers, including the cost of care, accessibility and low health literacy. In this interview, we explore how industry leaders are tackling these challenges to improve global oral health. Xtalks spoke to Dr. Maria Ryan, executive vice president and chief clinical officer at Colgate-Palmolive, and Allison Neale, vice president of Public Policy at Henry Schein, Inc. and manag
Survey reveals heavy burden of chronic hand eczema
pharmaphorum
JULY 4, 2024
UK survey finds more than two-thirds of people with chronic hand eczema say it has affected their relationships and/or working life.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
US govt gives $176m to Moderna for bird flu vaccine
pharmaphorum
JULY 4, 2024
The US government has signed a $176 million deal with Moderna to develop an mRNA-based pandemic influenza vaccine.
ReciBioPharm’s Edita Botonjic-Sehic, on analytics, AI, and continuous RNA manufacturing
BioPharma Reporter
JULY 4, 2024
RNA therapeutics have emerged as a transformative approach to treating many conditions, but the industry still typically relies on inefficient batch manufacturing methods.
Deep learning AI predicts response to cancer treatment
pharmaphorum
JULY 4, 2024
AI developed by Pangea Biomed predicts the chances that a patient will respond to cancer treatment by looking at tumour images.
Eli Lilly boosts radiopharmaceuticals focus with $140 million radionetics partnership
Outsourcing Pharma
JULY 4, 2024
Under the terms of the agreement, Eli Lilly will obtain the exclusive rights to acquire Radionetics Oncology for $1 billion.
Judge kicks out another Medicare price negotiation challenge
pharmaphorum
JULY 4, 2024
A Connecticut federal judge has rejected Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme.
FDA approves Kisunla for early Alzheimer's treatment amid cognitive decline slowdown
BioPharma Reporter
JULY 4, 2024
Eli Lilly has finally achieved FDA approval for its monoclonal antibody Alzheimerâs therapy donanemab, bringing new competition to the field for Eisai and Biogen.
Keensight Capital supports CatSci for ownership of specialist chromatography provider Reach Separations
Outsourcing Pharma
JULY 4, 2024
CatSci, a UK-based innovation partner for the development of pharmaceutical manufacturing processes, will be expanding its service offering with the acquisition of Reach Separations.
Ones to watch - five upcoming companies on the CAR-T scene
BioPharma Reporter
JULY 4, 2024
CAR-T therapies have big potential to take on blood cancer but also have major drawbacks.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Tyra Biosciences' TYRA-300 shows promise for hypochondroplasia treatment
Outsourcing Pharma
JULY 4, 2024
Preclinical results show promise for Tyra Bioscienceâs lead drug candidate for the treatment for hypochondroplasia, a condition for which there are currently no therapeutic options available.
Which pharmaceutical companies have the most gas dosed drugs?
Drug Patent Watch
JULY 4, 2024
This chart shows the pharmaceutical companies with the most gas dosed drugs. For a different perspective, see the most popular dosage types.
Pharma Pulse 7/4/24: Semaglutide Associated with Optic Neuropathy That Can Lead to Blindness, FDA Approves Lilly’s Kisunla & more
Pharmaceutical Commerce
JULY 4, 2024
The latest news for pharma industry insiders.
New tentative approval for Alembic drug dabigatran etexilate mesylate
Drug Patent Watch
JULY 4, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
UPS Healthcare Financially Commits Over $21.6 Million Toward Cold-Chain Fleet
Pharmaceutical Commerce
JULY 4, 2024
The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France Italy, and Hungary.
CDISC Standards for Biostatistics and Clinical Data Management
ProRelix Research
JULY 4, 2024
Collating and integrating data from a myriad of sources especially in global clinical trials requires that the data be in an accurate, reliable, and consistent format. The application of standards […] The post CDISC Standards for Biostatistics and Clinical Data Management appeared first on ProRelix Research.
Nestlé Health Science’s GLP-1 Nutrition Platform + Food IPOs of 2024
XTalks
JULY 4, 2024
Nestlé Health Science recently introduced an innovative platform, GLP-1 Nutrition. The newly launched website is designed to provide comprehensive nutritional support for individuals on their weight management journey, including those using glucagon-like peptide-1 (GLP-1) medications. In this episode of the Xtalks Food Podcast, Sydney talks about the platform, which serves as a comprehensive hub for individuals on a weight management journey.
Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data
XTalks
JULY 4, 2024
The pharma industry is poised for significant transformations in 2024, driven by groundbreaking drugs that have set new benchmarks in the industry. This blog delves into the top 30 drugs to watch in 2024, leveraging insights from their sales performance in 2023. These medications have not only redefined therapeutic standards across various medical conditions but have also showcased impressive sales figures, innovative advancements and expanded indications.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content